BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10869398)

  • 1. Dextromethorphan and its metabolite dextrorphan block alpha3beta4 neuronal nicotinic receptors.
    Hernandez SC; Bertolino M; Xiao Y; Pringle KE; Caruso FS; Kellar KJ
    J Pharmacol Exp Ther; 2000 Jun; 293(3):962-7. PubMed ID: 10869398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dextrometorphan and dextrorphan on nicotine and neuronal nicotinic receptors: in vitro and in vivo selectivity.
    Damaj MI; Flood P; Ho KK; May EL; Martin BR
    J Pharmacol Exp Ther; 2005 Feb; 312(2):780-5. PubMed ID: 15356218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of rat alpha3beta4 nicotinic receptor function by methadone, its metabolites, and structural analogs.
    Xiao Y; Smith RD; Caruso FS; Kellar KJ
    J Pharmacol Exp Ther; 2001 Oct; 299(1):366-71. PubMed ID: 11561100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus properties of dextromethorphan in rats.
    Gavend M; Mallaret M; Dematteis M; Baragatti G
    Biomed Pharmacother; 1995; 49(10):456-64. PubMed ID: 8746072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan.
    Lauterbach EC
    Med Hypotheses; 2012 Jun; 78(6):693-702. PubMed ID: 22401777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of dextromethorphan and dextrorphan on nicotine discrimination in rats.
    Wright MJ; Vann RE; Gamage TF; Damaj MI; Wiley JL
    Pharmacol Biochem Behav; 2006 Nov; 85(3):507-13. PubMed ID: 17112574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is antagonism of alpha3beta4 nicotinic receptors a strategy to reduce morphine dependence?
    Taraschenko OD; Panchal V; Maisonneuve IM; Glick SD
    Eur J Pharmacol; 2005 Apr; 513(3):207-18. PubMed ID: 15862802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan.
    Chou YC; Liao JF; Chang WY; Lin MF; Chen CF
    Brain Res; 1999 Mar; 821(2):516-9. PubMed ID: 10064839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dextrorotatory morphinans on alpha3beta4 nicotinic acetylcholine receptors expressed in Xenopus oocytes.
    Lee JH; Shin EJ; Jeong SM; Kim JH; Lee BH; Yoon IS; Lee JH; Choi SH; Lee SM; Lee PH; Kim HC; Nah SY
    Eur J Pharmacol; 2006 Apr; 536(1-2):85-92. PubMed ID: 16563374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of dextromethorphan, dextrorphan, and levorphanol on the hypothalamo-pituitary-adrenal axis.
    Pechnick RN; Poland RE
    J Pharmacol Exp Ther; 2004 May; 309(2):515-22. PubMed ID: 14742749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dextrorphan and dextromethorphan: comparative antitussive effects on guinea pigs.
    Braga PC; Fossati A; Vimercati MG; Caputo R; Guffanti EE
    Drugs Exp Clin Res; 1994; 20(5):199-203. PubMed ID: 7875056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-methyl-D-aspartate (NMDA) antagonists--S(+)-ketamine, dextrorphan, and dextromethorphan--act as calcium antagonists on bovine cerebral arteries.
    Kamel IR; Wendling WW; Chen D; Wendling KS; Harakal C; Carlsson C
    J Neurosurg Anesthesiol; 2008 Oct; 20(4):241-8. PubMed ID: 18812887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma profile and pharmacokinetics of dextromethorphan after intravenous and oral administration in healthy dogs.
    Kukanich B; Papich MG
    J Vet Pharmacol Ther; 2004 Oct; 27(5):337-41. PubMed ID: 15500572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of dextromethorphan and dextrorphan on morphine, methamphetamine, and nicotine self-administration in rats.
    Glick SD; Maisonneuve IM; Dickinson HA; Kitchen BA
    Eur J Pharmacol; 2001 Jun; 422(1-3):87-90. PubMed ID: 11430918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextromethorphan and dextrorphan in rats: common antitussives--different behavioural profiles.
    Dematteis M; Lallement G; Mallaret M
    Fundam Clin Pharmacol; 1998; 12(5):526-37. PubMed ID: 9794151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of dextrorphan.
    Fossati A; Vimercati MG; Caputo R; Valenti M
    Arzneimittelforschung; 1995 Nov; 45(11):1188-93. PubMed ID: 8929237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action.
    Werling LL; Lauterbach EC; Calef U
    Neurologist; 2007 Sep; 13(5):272-93. PubMed ID: 17848867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dextromethorphan on reference memory assessed in rats by a three-panel runway task.
    Göçmez SS; Erden BF; Ulak G; Utkan T; Yildiz F; Gacar N; Mutlu O
    Arzneimittelforschung; 2006; 56(4):276-81. PubMed ID: 16724513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
    Vann RE; Rosecrans JA; James JR; Philibin SD; Robinson SE
    Brain Res; 2006 Oct; 1117(1):18-24. PubMed ID: 16949560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative antitussive effects of dextrorphan, dextromethorphan and phencyclidine.
    Lal J; Krutak-Krol H; Domino EF
    Arzneimittelforschung; 1986 Jul; 36(7):1075-8. PubMed ID: 3768075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.